#prostatecancer search results
Is blogger Dan Zeller willing to just monitor his situation and delay treatment for prostate cancer? Plus, a primer on hormone therapy. #ProstateCancer cancerhealth.com/blog/prostate-…
Hot flashes affect most men on ADT! We've lacked good options. Oxybutynin, an old drug, may change that. The NKB pathway shows us why. 🔥 @CaPsurvivorship @ASCO @JCO_ASCO @OncoAlert @OncBrothers @APCCC_Lugano #prostatecancer DOI: 10.1200/JCO-26-00144
Collaborators with Drs. Strynadka, Andersen, and Sadar leveraged a library of androgen receptor (AR)-TAD inhibitors using cultured #ProstateCancer cells Alterations in the chemical scaffold impacted selectivity and potency within the AR-transcriptome. go.nature.com/42mnogZ
🔬 AI predicts #prostatecancer molecular subtypes directly from H&E biopsy slides 🧬 Digital path in @Nature_NPJ 🎯 AUC 0.863 (PAM50) | 0.81 (PSC) 💊Luminal B → predicts hormone therapy response ⚠️Luminal B & LP → flags aggressive pathology at surgery ⭐️Cheaper. Faster.
TMPRSS2:ERG–directed radiosensitization: exploiting DNA repair rewiring in gene fusion–positive #ProstateCancer: doi.org/10.1172/JCI203… Xiaoju Wang & Arul M. Chinnaiyan @ArulChinnaiyan @UMichMedSchool provide a Commentary on Köcher et al.: doi.org/10.1172/JCI194…
Facilitating precision therapy in #ProstateCancer… doi.org/10.1172/JCI194… Wael Y. Mansour & team @UKEHamburg discover ERG overexpression as a biomarker for identifying patients with prostate cancer who can benefit from #PARPi-based radiosensitization, enhancing radiotherapy
.@NorthwesternMed scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are treated. #ProstateCancer @NUFeinbergMed news.feinberg.northwestern.edu/2026/04/15/und…
Honored to have been invited to serve on @ASCO’s Metastatic Castration-Resistant Prostate Cancer Living Guideline Panel. Grateful for the opportunity to contribute to evidence-based guidance in prostate cancer care. #GUOnc #ProstateCancer #pcsm #MedTwitter #OncTwitter
🚨Tansdermal Estradiol (tE2) vs ADT for locally advanced #prostatecancer🚨 @NEJM New phase 3 RCT (PATCH/STAMPEDE-1) 🔑tE2 patches are noninferior to LHRH agonists for metastasis-free survival (n=1,360) ✅ 87.1% vs 85.9% 3-yr MFS 🌡️ Way fewer hot flashes (44% vs 89%) 🦴
🏥 'Had minor #medical issue...': #Netanyahu says he was successfully treated for #prostatecancer 🙏 | tinyurl.com/muy8mavd
CAPTAIN Trial Results — by the numbers. This randomized trial enrolled 211 men with localized intermediate-risk #prostatecancer, comparing MRI-guided #TULSAprocedure to robotic prostatectomy. The data shows meaningful differences in recovery, function, and time back to life.
#prostate #prostatecancer #cancer #urology #menshealth #health #prostatehealth #kidney #urologia #prostata #men #endourology #over Beware: 3 Common Foods Linked to Prostate Enlargement. 👇Click to learn more 👉 f.mtr.cool/bduimlxfqh 👈
#prostate #prostatecancer #cancer #urology #menshealth #health #prostatehealth #kidney #urologia #prostata #men #endourology #over Space Secrets: Astronauts' Prostate Wisdom. See how to fix👇prostate issues in the video. 👉 f.mtr.cool/tzouraqgrn 👈
Don't Miss! The #APCCC26 Consensus Meeting focuses on real-world #ProstateCancer management. @Silke_Gillessen joins @neerajaiims to discuss the upcoming 10th aniversary meeting, Apr 30th - May 2nd, shaping how we manage advanced prostate cancer in the real world and tackling
🚨Focal v radical salvage therapy for radiorecurrent #prostatecancer🚨 We invited @AJWLight to discuss this 🔥 topic during #EAU26 on this episode of the #UroOncMinute @IP_London @NIHRresearch @NorthLonUrol @UrologyTimes
In this episode of The UroOnc Minute, host Adam Weiner, MD, sits down with Alexander Light, MBBS, to discuss evolving strategies for salvage treatment in patients with radiorecurrent prostate cancer. #EAU26 Check out the full episode here: urologytimes.com/view/the-uroon…
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. Co-authored by @AarmstrongDuke. Read the full article. bit.ly/4dXXPK7 #ProstateCancer #pcsm
📢 Great starting!! Dr. Charles Sawyers addressing in the #AACR oppening lecture in transition from adenoCa to NEC in #prostatecancer at #IPCS26 @APCCC_Lugano @Silke_Gillessen 🇨🇭 @oncourologiaarg @fundacion_FUCA @vicare_asocia
#CancerHealthStories A New Kind of Intimacy - Robert Ginyard, 57, lives in Baltimore with his wife and two children. #prostatecancer #cancer cancerhealth.com/article/new-ki…
For #ProstateCancer, there are three types 🐢🐇🐦⬛
PROSTATE CANCER IS A SPECTRUM Tortoises. Rabbits. Birds. Not all prostate cancer behaves the same way. Some tumors grow very slowly and may never cause harm. These are often lower-risk cancers, commonly referred to as Gleason 6 or Grade Group 1, and many men with this type of
Is blogger Dan Zeller willing to just monitor his situation and delay treatment for prostate cancer? Plus, a primer on hormone therapy. #ProstateCancer cancerhealth.com/blog/prostate-…
ઇઝરાયલ PM નેતન્યાહુને પ્રોસ્ટેટ કેન્સર; પુરુષો માટે સાયલન્ટ ખતરો, 50 વર્ષ પછી દર વર્ષે સ્ક્રીનિંગ કરાવવું જરૂરી; લક્ષણો અને બચાવના ઉપાય - divya.bhaskar.com/cf4Z5X7KH2b #PhysicalHealth #ProstateCancer #Cancer #Health #Lifestyle
Collaborators with Drs. Strynadka, Andersen, and Sadar leveraged a library of androgen receptor (AR)-TAD inhibitors using cultured #ProstateCancer cells Alterations in the chemical scaffold impacted selectivity and potency within the AR-transcriptome. go.nature.com/42mnogZ
#prostate #prostatecancer #cancer #urology #menshealth #health #prostatehealth #kidney #urologia #prostata #men #endourology #over Space Secrets: Astronauts' Prostate Wisdom. See how to fix👇prostate issues in the video. 👉 f.mtr.cool/tzouraqgrn 👈
👏Well deserved accolade for Rob who has contributed so much to the field of #prostatecancer @PCFnews @PCF_Science @UCLAHealthJCCC @UclaUrology
We’re proud to announce the recipients of the 2026 Urology Care Foundation Research Awards of Distinction—leaders whose groundbreaking research, mentorship, and innovation are advancing urologic care and shaping the future of our field. 👏 Congratulations to all of this year’s
@CooperHealthNJ offers @FocalOneHIFU, the latest noninvasive, nonsurgical option in the management of prostate cancer. There is no surgery, no blood loss, and no radiation. Watch the video to learn more. #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
Prostate cancer treatment doesn’t always mean surgery. At MD Anderson Cancer Center at Cooper, we offer advanced options like high-intensity ultrasound – a non-surgical treatment that targets cancer while helping patients recover faster.
#CancerHealthStories A New Kind of Intimacy - Robert Ginyard, 57, lives in Baltimore with his wife and two children. #prostatecancer #cancer cancerhealth.com/article/new-ki…
How have the PACE trials influenced radiotherapy treatment for #ProstateCancer to date? Profs Emma Hall & @nickva1 at the ICR discuss learnings from a decade of trials, including @ProstateUK-funded PACE-NODES, in @IJROBP. Grab a ☕ & read: doi.org/10.1016/j.ijro…
We are delighted to be supporting the South West Urology Annual Meeting over the next couple of days, showcasing our #NanoKnife #IRE system for #ProstateCancer, #Biobot delivering robotic precision for #ProstateDisease, and our cost-effective, quality #biopsy solutions #Urology
The next step in AR degradetors in #prostatecancer are #RIPTACS..... The "hold & kill" Moa. By Dr Armstrong at #IPCS26 @APCCC_Lugano @Silke_Gillessen @oncourologiaarg @vicare_asocia
Don't Miss! The #APCCC26 Consensus Meeting focuses on real-world #ProstateCancer management. @Silke_Gillessen joins @neerajaiims to discuss the upcoming 10th aniversary meeting, Apr 30th - May 2nd, shaping how we manage advanced prostate cancer in the real world and tackling
Honored to have been invited to serve on @ASCO’s Metastatic Castration-Resistant Prostate Cancer Living Guideline Panel. Grateful for the opportunity to contribute to evidence-based guidance in prostate cancer care. #GUOnc #ProstateCancer #pcsm #MedTwitter #OncTwitter
⚠️ The timing for presenting neoadjuvant therapy in #prostatecancer by Dr Briganti while awaiting the results of Proteus could not be more appropriate @APCCC_Lugano #IPCS26 Still missing.... How to identify the responders❓ @Silke_Gillessen @oncourologiaarg @fundacion_FUCA
❓ Do you think clinicians should continue imaging surveillance for radiographic progression despite stable PSA in advanced #prostatecancer? 🔎 See what a recent analysis discovered about the use of periodic surveillance imaging: buff.ly/HEoTnt0
Generative Artificial Intelligence for Medical Summarization in Prostate Cancer: Comparative Evaluation by Physicians and Patient Advocates—A Pilot Study. Read the full article. bit.ly/4cXbLC2 #ProstateCancer #pcsm
📢 Great starting!! Dr. Charles Sawyers addressing in the #AACR oppening lecture in transition from adenoCa to NEC in #prostatecancer at #IPCS26 @APCCC_Lugano @Silke_Gillessen 🇨🇭 @oncourologiaarg @fundacion_FUCA @vicare_asocia
CAPTAIN Trial Results — by the numbers. This randomized trial enrolled 211 men with localized intermediate-risk #prostatecancer, comparing MRI-guided #TULSAprocedure to robotic prostatectomy. The data shows meaningful differences in recovery, function, and time back to life.
Neue Erfolgsmeldung zu mRNA-Impfstoff gegen Pankreas-Ca; Überdiagnosen von Prostata-Ca; Waldbrände erhöhen Krebsrisiko; Myokarditis und Triple-M-Syndrom nach ICI #oncology, #prostatecancer, deutsch.medscape.com/viewarticle/%C…
Starting the #IPCS26... One of the most important conference in #prostatecancer with experts around the globe 🌏 @Silke_Gillessen @APCCC_Lugano
ઇઝરાયલ PM નેતન્યાહુને પ્રોસ્ટેટ કેન્સર; પુરુષો માટે સાયલન્ટ ખતરો, 50 વર્ષ પછી દર વર્ષે સ્ક્રીનિંગ કરાવવું જરૂરી; લક્ષણો અને બચાવના ઉપાયો #PhysicalHealth #ProstateCancer #Cancer #Health #Lifestyle divya.bhaskar.com/cf4Z5X7KH2b
#ASCOGU26 — POSEIDON Study Adding ADT to salvage radiotherapy after prostatectomy improves survival only when PSA > 0.5 ng/mL. For early recurrence (PSA ≤ 0.5), RT alone appears sufficient. Short-term ADT (4–6 months) is adequate. #ASCO #ProstateCancer #RadiationOncology
⭐️Can PSMA PET augment #ProstateCancer detection?? 🔬Only one way to find out! Trial in the works via @clintbahler & Wayne Brisbane @PSMAconference 2026 @UclaUrology @IUuro @CalaisJeremie @PCFnews @PCF_Science
For #ProstateCancer, there are three types 🐢🐇🐦⬛
PROSTATE CANCER IS A SPECTRUM Tortoises. Rabbits. Birds. Not all prostate cancer behaves the same way. Some tumors grow very slowly and may never cause harm. These are often lower-risk cancers, commonly referred to as Gleason 6 or Grade Group 1, and many men with this type of
Our Specialist Nurses will return on Tuesday 7 April, but there are other ways for you to get support over #Easter. 💬 There's no such thing as a silly question and we're also here to help your loved ones. ➡️ Get in touch: bit.ly/4sDXd0c #ProstateCancer l #Support
So grateful to @yunroseli for bringing @ASTRO_org Pres @NehaVapiwala from @PennCancer to headline our @cityofhope GU retreat! A terrific talk on oligometastatic #prostatecancer (standing room only!) to kick off an exciting agenda w @WesleyYipMD, @charlesbnguyen, @arafflemd,
🚨PARP-I for #prostatecancer “In order to move to earlier stage disease, we will need to see survival benefit” Wise words from @AttardLab 1/3 of patients require a blood transfusion - have to balance these costs with clear benefits @Uroweb #EAU26 @PCFnews @urotoday
🚨Germline and somatic alterations in #ProstateCancer Great summary by @Dolmos77 Prioritizing education on molecular alterations hugely valuable at #EAU26 @Uroweb @urotoday @UrologyTimes @PCFnews
🚨Tansdermal Estradiol (tE2) vs ADT for locally advanced #prostatecancer🚨 @NEJM New phase 3 RCT (PATCH/STAMPEDE-1) 🔑tE2 patches are noninferior to LHRH agonists for metastasis-free survival (n=1,360) ✅ 87.1% vs 85.9% 3-yr MFS 🌡️ Way fewer hot flashes (44% vs 89%) 🦴
ONE WEEK TO GO ⤵️ Join our FREE online webinar, led by our Specialist Nurses, about living well during and after #Radiotherapy for #ProstateCancer. 🗓️ Tuesday 21 April ⏰ 6-7:30pm ➡️ Book your spot: bit.ly/4m1jKBY
🚨Dual PET for treatment naive #prostatecancer🚨 The combination of PSMA and FAPI-based PET can localize more metastatic and primary cancers compared with PSMA alone 👉 Still need to determine who would benefit most from an additional PET @Uroweb @UrologyTimes #EAU26
🚨Biparametric MRI for detectng #ProstateCancer🚨 Great chatting w/ @veerukasi on the #UroOncMinute #EAU26 @Uroweb @UrologyTimes @PCFnews @PCF_Science @BURSTUrology @COMPASSurology @UCL @UCLH @clecliniclondon 🔗shorturl.at/wx6DS
For the first time ever, we have a TRIPLE header day ahead of us 🏃 Good luck to everyone taking on @LLHalf, @BrightonMarathn and @ParisMarathon tomorrow. 💙 Thank you for helping us work towards a future where no man dies from #ProstateCancer. #Marathon l #HalfMarathon
Do you have questions about #Radiotherapy? 💭 Join our FREE online webinar, led by our Specialist Nurses, about living well during and after radiotherapy for #ProstateCancer. 🗓️ Tuesday 21 April ⏰ 6-7:30pm ➡️ Book your spot: bit.ly/4m1jKBY
Have you discovered The Prostate Health Hub yet? 🤔 It's our welcoming online space for anyone affected by #ProstateCancer. This isn’t a science journal. It’s a place for relatable stories, health and wellbeing tips and so much more. ➡️ Sign up today: bit.ly/4stBuHC
🚨Prelim data from Weiner Lab on biologic correlates with PSMA in localized #ProstateCancer Much more to come on our lab’s major work! @PSMAconference @CSCancerCenter @PCFnews @PCF_Science
Can CAR T finally crack #mCRPC? Investigational all-in-one CAR T-Cell platform for #ProstateCancer. @NourShobaki @PennMedicine joins @zklaassen_md @GACancerCenter to discuss an all‑in‑one CAR T platform targeting STEAP2 and locally secreting PSMA‑CD28 bispecifics to turn
🔬 AI predicts #prostatecancer molecular subtypes directly from H&E biopsy slides 🧬 Digital path in @Nature_NPJ 🎯 AUC 0.863 (PAM50) | 0.81 (PSC) 💊Luminal B → predicts hormone therapy response ⚠️Luminal B & LP → flags aggressive pathology at surgery ⭐️Cheaper. Faster.
This is what football’s all about 💙 Danny was diagnosed with incurable #ProstateCancer in 2021. This #NonLeagueDay, @OssettUnited centred the day around him, making him assistant manager for their game. ➡️ Read more: bit.ly/4c3IjJX @NonLeagueDayUK
Considerations for managing patients as they progress to castration-resistant #ProstateCancer. @TiansterZhang @UTSWMedCenter joins @zklaassen_md @GACancerCenter outlining management strategies for patients progressing from metastatic hormone-sensitive to castration-resistant
Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision Therapy academic.oup.com/oncolo/advance… This study analyzed 22,061 advanced #ProstateCancer cases to evaluate homologous recombination deficiency (HRD) signatures and BRCA2
Something went wrong.
Something went wrong.
United States Trends
- 1. Comey N/A
- 2. king charles N/A
- 3. Mark Pope N/A
- 4. Stokes N/A
- 5. #WWENXT N/A
- 6. Kansas N/A
- 7. Adam Silver N/A
- 8. Bayern N/A
- 9. #thisisjimin N/A
- 10. O Canada N/A
- 11. NCAA N/A
- 12. blanche N/A
- 13. Casey Mize N/A
- 14. Bill Self N/A
- 15. McBride N/A
- 16. Tyler Myers N/A
- 17. Bondi N/A
- 18. Rock Chalk N/A
- 19. March Madness N/A
- 20. #ShootingStar N/A